Rapid Micro Biosystems, Inc. financial data

Symbol
RPID on Nasdaq
Industry
Laboratory Analytical Instruments
Location
25 Hartwell Avenue, Lexington, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 571 % -28%
Quick Ratio 127 % -3.11%
Debt-to-equity 24.6 % +46.9%
Return On Equity -52.1 % -33.4%
Return On Assets -41.8 % -25%
Operating Margin -178 % +29.2%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 28.2M USD 0%
Weighted Average Number of Shares Outstanding, Basic 43.6M shares +1.28%
Weighted Average Number of Shares Outstanding, Diluted 43.6M shares +1.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 28.1M USD +24.6%
Research and Development Expense 14.6M USD +13.9%
Selling and Marketing Expense 13.3M USD -0.42%
General and Administrative Expense 21.9M USD -12%
Costs and Expenses 78M USD -1.41%
Operating Income (Loss) -49.9M USD +11.7%
Nonoperating Income (Expense) 3.05M USD -26%
Income Tax Expense (Benefit) 22K USD -29%
Net Income (Loss) Attributable to Parent -46.9M USD +10.6%
Earnings Per Share, Basic -1.08 USD/shares +11.5%
Earnings Per Share, Diluted -1.08 USD/shares +11.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.9M USD -30.4%
Accounts Receivable, after Allowance for Credit Loss, Current 7.52M USD +35.9%
Inventory, Net 20.2M USD +1.2%
Other Assets, Current 843K USD +46.1%
Assets, Current 80.9M USD -32.8%
Property, Plant and Equipment, Net 11.2M USD -12.8%
Operating Lease, Right-of-Use Asset 5M USD -16.3%
Other Assets, Noncurrent 531K USD -31%
Assets 98.2M USD -31.6%
Accounts Payable, Current 2.54M USD +28.5%
Employee-related Liabilities, Current 4.46M USD -7.16%
Accrued Liabilities, Current 7.22M USD -27.2%
Contract with Customer, Liability, Current 6.6M USD +10.5%
Liabilities, Current 17.6M USD -7.48%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 4.78M USD -19.6%
Other Liabilities, Noncurrent 298K USD +13.3%
Liabilities 22.8M USD -10.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 39K USD
Retained Earnings (Accumulated Deficit) -475M USD -10.9%
Stockholders' Equity Attributable to Parent 75.4M USD -36.1%
Liabilities and Equity 98.2M USD -31.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.5M USD +6.96%
Net Cash Provided by (Used in) Financing Activities 158K USD +29.5%
Net Cash Provided by (Used in) Investing Activities 13.5M USD -2.84%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17.3M USD -29.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9K USD -10%
Deferred Tax Assets, Valuation Allowance 82.6M USD +16.1%
Deferred Tax Assets, Gross 84.1M USD +15.4%
Operating Lease, Liability 5.95M USD -15.5%
Payments to Acquire Property, Plant, and Equipment 585K USD -22.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46.7M USD +9.15%
Lessee, Operating Lease, Liability, to be Paid 6.48M USD -17.1%
Property, Plant and Equipment, Gross 27.7M USD +2.11%
Operating Lease, Liability, Current 1.17M USD +7.06%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.4M USD +2.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.37M USD +2.55%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 526K USD -31.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.44M USD +2.35%
Deferred Tax Assets, Operating Loss Carryforwards 65.3M USD +17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.47M USD +2.3%
Operating Lease, Payments 331K USD +4.75%
Additional Paid in Capital 550M USD +0.75%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 806K USD +6.19%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 3.87M USD -18.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%